- Pressure BioSciences ( OTC:PBIO ) said on Thursday it had entered manufacturing, sales, and distribution agreement with Canopy CBD Farms, a Massachusetts licensed processor, manufacturer and distributor of hemp-derived CBD products and processing equipment.
- CCF, which has a strong presence in Massachusetts, New England hemp-derived CBD market and with hundreds of industry connections nationwide, has assembled an aggressive distribution plan that anticipates nano-CBD product sales of nearly $6M over the first 12-months post-release.
- PBI believes it will capture about $2M of CCF's expected product revenue and expects launch in October.
- ""Our PBI team is incredibly excited as we now transition into production of UST-based products and what we believe will be impressive and highly profitable product revenues in late 2022, then accelerating into 2023 and beyond," PBIO said.
For further details see:
Pressure Biosciences announces contract for October launch of hemp-derived CBD product